Evidence map›Paper›PMID 40936741›Full record

ArticleInternational journal of mental health and addiction2024

EFFECTIVENESS OF A POST-DISCHARGE PHONE-BASED SMOKING CESSATION INTERVENTION FOR PATIENTS WITH SEVERE MENTAL HEALTH DISORDERS: THE 061 QUITMENTAL RANDOMIZED CONTROLLED CLINICAL TRIAL.

Cristina Martínez, Ariadna Feliu, Judith Saura, Gemma Nieva, Cristina Pinet, Antònia Raich, Sílvia Mondon, Pablo Barrio, Magalí Andreu, Rosa Hernández-Ribas and 11 more

Abstract read
In one paragraph

Article in International journal of mental health and addiction, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

21 authors.

Cristina MartínezTobacco Control Unit, Cancer Control and Prevention Program, Institut Català d'Oncologia-ICO, Av. Gran Via de L'Hospitalet 199-203, 08908 L'Hospitalet de Llobregat (Barcelona), Spain.
Ariadna FeliuTobacco Control Unit, Cancer Control and Prevention Program, Institut Català d'Oncologia-ICO, Av. Gran Via de L'Hospitalet 199-203, 08908 L'Hospitalet de Llobregat (Barcelona), Spain.
Judith SauraTobacco Control Unit, Cancer Control and Prevention Program, Institut Català d'Oncologia-ICO, Av. Gran Via de L'Hospitalet 199-203, 08908 L'Hospitalet de Llobregat (Barcelona), Spain.
Gemma NievaMental Health and Addiction Research Group, Vall d'Hebron Institut de Recerca (VHIR), Vall d'Hebron Hospital Universitari, Barcelona, Spain; Mental Health Department, Vall d'Hebron Hospital Universitari, Passeig Vall d'Hebron 119-129, 08035 Barcelona, Spain.
Cristina PinetAddictive Behaviors Unit, Psychiatry Department, Hospital de la Santa Creu i Sant Pau, C. San Antoni Mª Claret 167, 08025 Barcelona, Spain.
Antònia RaichMental Health Department, Althaia Xarxa Assistencial Universitària, C. Dr. Llatjós s/n, 08243 Manresa (Barcelona), Spain.
Sílvia MondonAddictions Unit, Psychiatry Department, Institute of Neurosciences, Hospital Clínic de Barcelona. C. Villarroel 170, 08036 Barcelona, Spain.
Pablo BarrioAddictions Unit, Psychiatry Department, Institute of Neurosciences, Hospital Clínic de Barcelona. C. Villarroel 170, 08036 Barcelona, Spain.
Magalí AndreuAddictions Unit, Psychiatry Department, Institute of Neurosciences, Hospital Clínic de Barcelona. C. Villarroel 170, 08036 Barcelona, Spain.
Rosa Hernández-RibasAlcohol Program, Psychiatry Department, Hospital Universitari de Bellvitge. Institut Català d'Oncologia. IDIBELL. CIBERSAM. Feixa Llarga s/n, 08907 L'Hospitalet de Llobregat (Barcelona), Spain.
Sílvia CostaAddictive Behaviors Unit, Psychiatry Department, Hospital de la Santa Creu i Sant Pau, C. San Antoni Mª Claret 167, 08025 Barcelona, Spain.
Josep Maria SuelvesPublic Health Agency of Catalonia, Health Department, Government of Catalonia, C. Roc Boronat 81-95, 08005 Barcelona, Spain.
Jordi VilaplanaSerra Húnter Fellow / Computer Science Department, University of Lleida, Jaume II, 69, 25001, Lleida, Spain.
Marta EnríquezTobacco Control Unit, Cancer Control and Prevention Program, Institut Català d'Oncologia-ICO, Av. Gran Via de L'Hospitalet 199-203, 08908 L'Hospitalet de Llobregat (Barcelona), Spain.
Laura AlaustreMental Health and Addiction Research Group, Vall d'Hebron Institut de Recerca (VHIR), Vall d'Hebron Hospital Universitari, Barcelona, Spain; Mental Health Department, Vall d'Hebron Hospital Universitari, Passeig Vall d'Hebron 119-129, 08035 Barcelona, Spain.
Eva Vilalta061 CatSalut Respon, Sistema d'Emergències Mèdiques. C. Pablo Iglesias 115, 08908 L'Hospitalet de Llobregat (Barcelona), Spain.
Judit Bonet AlvarezMental Health Department, Althaia Xarxa Assistencial Universitària, C. Dr. Llatjós s/n, 08243 Manresa (Barcelona), Spain.
Joseph GuydishPhilip R. Lee Institute for Health Policy Studies, University of California San Francisco, 490 Illinois St., 7 floor, San Francisco, CA 94158, United States.
061 Quitmental Group
Esteve FernándezTobacco Control Unit, Cancer Control and Prevention Program, Institut Català d'Oncologia-ICO, Av. Gran Via de L'Hospitalet 199-203, 08908 L'Hospitalet de Llobregat (Barcelona), Spain.
Montse BallbèTobacco Control Unit, Cancer Control and Prevention Program, Institut Català d'Oncologia-ICO, Av. Gran Via de L'Hospitalet 199-203, 08908 L'Hospitalet de Llobregat (Barcelona), Spain.

Funding

Marketing, FDA communication, tobacco perceptions and use in addiction treatmentR01DA036066 · NIDA · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI GUYDISH, JOSEPH R · 2013 to 2016
$3.0M
NIDA NIH HHS R01 DA036066
6 · The paper itself

Abstract

A pragmatic double-blind randomized controlled trial was conducted in Barcelona to assess a telephone-based smoking cessation intervention's effectiveness for individuals with mental health disorders post-discharge. Participants were divided into an Intervention Group (IG) and Control Group (CG) with a 2:1 allocation ratio. The IG received proactive motivational assistance, while the CG received brief advice. Biochemically validated past 7-day abstinence was the main outcome measure. Of 530 screened individuals, 294 were enrolled (200 IG, 94 CG). During follow-up, participants reported 97 episodes of ≥7-day abstinence (IG: 51, CG: 26). Overall abstinence probability was 30-35%, with no difference between groups at one-year follow-up. However, intervention participants were more likely to report abstinence if they quit during hospitalization or were considering quitting. The intervention effectively supported smoking abstinence in motivated individuals. Combining this with clinical and community-based interventions holds promise for aiding smoking cessation in those with mental disorders.

Identifiers

PMID40936741
PMCPMC12421409

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.